Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)
Clinical trial NCT03538626 · COMPLETED
Trial details
- NCT number
- NCT03538626
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-21
- Primary completion
- 2022-08-29
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.